IL17A and melanoma: We next focused our attention to the melanoma models exposing bcl-2 overexpressing melanoma cells to either anti-IL-1β, anti-IL-17 or anti-IL-8 blocking antibodies and analyzing their impact on the expression of the identified bcl-2-inducible factors.